Torna ai risultati
Scheda bibliografica · Consultazione e accesso
Artículo de revista

Development of Reversible Posterior Leukoencephalopathy Syndrome after Cyclophosphamide Treatment in a Patient with Lupus Nephritis

Serkan YILDIZ et al · Turkish Society of Nephrology · 2019

Testo completo ad accesso aperto
Lettura rapida. Controlla i dati essenziali della risorsa e accedi al contenuto con il pulsante principale. La scheda mostra solo le informazioni necessarie per identificare, citare e aprire l’opera.
Pubblicazione seriale

"ONE HUNDRED AND THIRTY-FIVE HOURS UNDER THE RUIN : A CASE WITH TRAUMATIC RHABDOMYOLYSIS IN GÖLCÜK EARTHQUAKE"

Questa pubblicazione seriale contiene 1.344 contenuti correlati.

Accesso alla risorsa

Apri il contenuto dall’opzione principale o scegli un’altra fonte disponibile.

DOAJ DOAJ Articles
Entrar por DOAJ
Accesso principale

Testo completo ad accesso aperto

Texto completo identificado como acceso abierto.
Apri testo
Otras opciones de acceso Elegí el proveedor disponible para esta ficha.
DOAJ CSV Export DOAJ - Open Access Journals
Acceder por DOAJ CSV Export
DOAJ OAI-PMH DOAJ Articles
Acceder por DOAJ OAI-PMH

Altre opzioni disponibili

Se la risorsa è presente su più piattaforme, puoi scegliere dove aprirla.

DOAJ CSV Export DOAJ - Open Access Journals Accesso disponibile
Apri
DOAJ OAI-PMH DOAJ Articles Accesso disponibile
Apri

Riepilogo

Descripción general del contenido del recurso.

Renal involvement in systemic lupus erythematosus is a frequent and serious complication that significantly increases morbidity and mortality. Despite all studies and usage of new drugs, treatment of lupus nephritis continues to be a problem. Diffuse proliferative lupus nephritis has a poor prognosis and aggressive treatment must be undertaken. Cyclophosphamide is commonly used in treatment despite its side effects. Reversible posterior leucoencephalopathy syndrome is a clinico-radiological syndrome manifested by blood pressure elevation, headache, visual disturbances, confusion, seizures and sometimes focal neurological signs that can develop due to usage of cytotoxic drugs. We present a case of lupus nephritis in which reversible posterior leucoencephalopathy syndrome developed after intravenous cyclophosphamide administration and recovered spontaneously by symptomatic treatment in this article.

Come citare

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

al, S. Y. E. (2019). Development of Reversible Posterior Leukoencephalopathy Syndrome after Cyclophosphamide Treatment in a Patient with Lupus Nephritis. https://turkjnephrol.org/index.php/pub/article/view/735

MLA

al, Serkan YILDIZ et. "Development of Reversible Posterior Leukoencephalopathy Syndrome after Cyclophosphamide Treatment in a Patient with Lupus Nephritis." 2019. https://turkjnephrol.org/index.php/pub/article/view/735.

Chicago

al, Serkan YILDIZ et. 2019. "Development of Reversible Posterior Leukoencephalopathy Syndrome after Cyclophosphamide Treatment in a Patient with Lupus Nephritis.". https://turkjnephrol.org/index.php/pub/article/view/735.

Harvard

al, S. Y. E. 2019, Development of Reversible Posterior Leukoencephalopathy Syndrome after Cyclophosphamide Treatment in a Patient with Lupus Nephritis, Turkish Society of Nephrology, available at: https://turkjnephrol.org/index.php/pub/article/view/735 [Accessed 6 Aug. 2026].

Condividi e stampa

Salva la scheda, copia il link permanente o stampala in PDF.

Esporta riferimento

Esporta il record nei formati più comuni per usarlo con un gestore bibliografico.

Dettagli della risorsa

Informazioni bibliografiche utili per verificare che sia il materiale corretto.

Titolo
Development of Reversible Posterior Leukoencephalopathy Syndrome after Cyclophosphamide Treatment in a Patient with Lupus Nephritis
Autore / collaboratori
Serkan YILDIZ et al
Editore
Turkish Society of Nephrology
Anno di pubblicazione
2019
ISSN
2667-4440
ISSN
2667-4440
Lingua
Inglés

Soggetti

Esplora risorse correlate a partire da questi soggetti.

Copiato